Manzo Pharmaceuticals Inc. (MNZO)

[investor_61]

No one has suggested the patent is a fraud. It is being suggested that the value and significance of the patent has been exaggerated. Does anyone really believe Ken Manzo is the only person in the Pharmaceutical "world" to have ever had such an idea? Also, MNZO's ability to take the patent, develop a product and take it to market has been wildly exaggerated. It could happen but the odds are one in a million. Ken Manzo is aware of this, so he's decided to tell a good story and hopefully make a bit of money on the stock. A non-disclosure, loosely regulated Pink Sheets shell was vital to his plan. The story falls apart under direct scrutiny.

As far as Celprogen is concerned, their involvement in all of this has also been wildly exaggerated. Ken Manzo needed technical help with his application for the patent and found Jay Sharma on the internet. Sharma handled the technical aspects of the patent application in exchange for a 1/2 interest in it. Later, when Manzo needed a lab to do testing, Jay Sharma's company was the natural choice. Sharma may be giving Manzo flexible terms for his company's work and might be taking a larger royalty from any product that might be developed from all of this, in lieu of payment, but that's where his, and Celprogen's, interest ends. Manzo offers nothing to Celprogen. Celprogen wouldn't pay $1 to acquire a messy situation like MNZO, let alone merge with it. If Celprogen wanted to go public, they'd just do it on their own. Why would a viable company want to merge with a bankrupt, Pink Sheets shell with no assets and no business. It makes no business sense.

If Celprogen wanted to develop a product like Lacto-Freedom, they'd alter the Manzo/Sharma patent slightly, apply for their own patent then develop it and take it to market. Period, end of story.